Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22497434 | 1.00 | MAPT (0.46) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL25911822 | 0.95 | MAPT (0.47) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| Acetic Acid SCHEMBL22497435 | 0.89 | MAPT (0.41) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| Acetic Acid SCHEMBL22497433 | 0.89 | MAPT (0.41) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| Acetic Acid SCHEMBL29503051 | 0.89 | MAPT (0.41) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL25911865 | 0.88 | MAPT (0.55) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL24858669 | 0.87 | MEN1 (0.39) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL18012789 | 0.86 | ATM (0.38) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL28704196 | 0.85 | MAPT (0.43) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 | |
| SCHEMBL18012700 | 0.83 | HDAC3 (0.35) | MAPTALDH1A1KMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250390020-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, CURED PRODUCT, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR MANUFACTURING PRINTED WIRING BOARD | RESONAC CORP (JP) | 2025-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250390020-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, CURED PRODUCT, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR MANUFACTURING PRINTED WIRING BOARD | MMAB, CD79B, ELOB | MAPT 1166/4885ALDH1A1 1085/4885KMT2A 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.